Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience

Journal of Neuro-Oncology 2026 Open access

Read full text
Authors: Angelo Dipasquale, Pasqualina Giordano, A. Bosio, Maarten M.J. Wijnenga, Laura Giordano, Agnese Losurdo, Pasquale Persico, Marta Padovan, Angela Viggiano, Giuseppe Catapano, Marjolein Geurts, Federico Pessina
+3 more A Santoro, Giuseppe Lombardi, Matteo Simonelli
DOI: 10.1007/s11060-026-05439-0
Cited by: 0
References: 20

Fields of Study & Subjects

Glioma Diagnosis and Treatment Acute Myeloid Leukemia Research PARP inhibition in cancer therapy

Publication details

Journal / source
Journal of Neuro-Oncology
Volume
176
Issue
3
Pages
186–186
Publication date
28 January 2026
Language
EN